Drug Reduces Mysterious Particle Involved in Heart Attack Risk
The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...
The American Journal of Managed Care4h
Abelacimab Shows Unprecedented Bleeding Risk Reduction in Patients With Atrial Fibrillation
Christian T. Ruff, MD, MPH, of Brigham and Women's Faulkner Hospital, discusses new data comparing abelacimab with ...
AFib diagnosed in midlife linked to 21% increased risk of dementia at any age, 36% higher risk of early-onset dementia
New research presented at the EHRA 2025, a scientific congress of the European Society of Cardiology, shows that the presence ...
The Cool Down on MSN1d
Thousands of people are ordering at-home tests to measure blood levels: 'I have long feared my body may be riddled'
Experts are still trying to figure out exactly what this might do to the human body. Thousands of people are ordering at-home ...
US FDA approves Sanofi's bleeding disorder therapy
The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...
European Medical Journal4d
Blood Plasma in Wound Healing: Breakthrough or Hurdle?
Blood plasma, fibrinogen, and fibrin have long been explored for their role in skin tissue engineering and dermatological ...
Tribune Content Agency on MSN4d
The Medicine Cabinet: Ask the Harvard Experts: The better names for blood thinners
Q: I was recently asked if I take a blood thinner. I wasn’t sure how to answer the question because I occasionally take ...